Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Saved in:
| Title: | Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry. |
|---|---|
| Authors: | Li A; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Musters AH; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Hyseni A; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Gerbens LAA; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Spuls PI; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. |
| Source: | The British journal of dermatology [Br J Dermatol] 2024 Nov 18; Vol. 191 (6), pp. 1012-1013. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
